Pub. Date : 2018 Mar
PMID : 29392451
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PURPOSE: Idasanutlin, a selective small-molecule MDM2 antagonist in phase 3 testing for refractory/relapsed AML, is a non-genotoxic oral p53 activator. | RG7388 | MDM2 proto-oncogene | Homo sapiens |
| 2 | Phase 1 summary of plasma concentration-QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML. | RG7388 | MDM2 proto-oncogene | Homo sapiens |